Tumor Prevention and Genetics III [electronic resource] /
International Conference on Controversies in Tumor Prevention and Genetics(3rd :2004 :Saint Gall, Switzerland)
Senn, H.-J.editor.
Morant, R.editor.
International Conference on Controversies in Tumor Prevention and Genetics(3rd :2004 :St. Gallen, Switzerland)
This volume contains the majority of the invited keynote lectures presented by experts at the Third International Conference on Controversies in Tumor Prevention and Genetics on 12-14 February 2004 in St. Gallen, Switzerland. Together, they reveal the latest findings in oncogenetics and its relations to recent and future developments in primary and secondary tumor prevention, especially in breast, colon and lung cancer. All contributions are written and have been critically reviewed by internationally recognised leaders in the field.
This volume contains the majority of the invited keynote lectures presented by experts at the Third International Conference on Controversies in Tumor Prevention and Genetics on 12-14 February 2004 in St. Gallen, Switzerland. Together, they reveal the latest findings in oncogenetics and its relations to recent and future developments in primary and secondary tumor prevention, especially in breast, colon and lung cancer. All contributions are written and have been critically reviewed by internationally recognised leaders in the field.
"This volume contains the majority of the invited keynote lectures presented by experts at the Third International Conference on Controversies in Tumor Prevention and Genetics on 12-14 February 2004 in St. Gallen, Switzerland"--Jacket.
Includes bibliographical references.
Lifestyle and Medical Approaches to Cancer Prevention -- Application of Genetics to the Prevention of Colorectal Cancer -- Genetics and Prevention of Oesophageal Adenocarcinoma -- Preclinical Models Relevant to Diet, Exercise, and Cancer Risk -- Individualizing Interventions for Cancer Prevention -- Can Animal Models Help Us Select Specific Compounds for Cancer Prevention Trials? -- Problems with Using Biomarkers as Surrogate End Points for Cancer: A Cautionary Tale -- Can a Marker Be a Surrogate for Development of Cancer, and Would We Know It if It Exists? -- How Should We Move the Field of Chemopreventive Agent Development Forward in a Productive Manner? -- The Problems with Risk Selection; Scientific and Psychosocial Aspects -- Chemoprevention of Lung Cancer -- Anti-nicotine Vaccination: Where Are We? -- Primary Prevention of Colorectal Cancer: Lifestyle, Nutrition, Exercise -- Chemoprevention of Colorectal Cancer: Ready for Routine Use? -- Screening of Colorectal Cancer: Progress and Problems -- The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence -- Innovative Agents in Cancer Prevention -- The IARC Commitment to Cancer Prevention: The Example of Papillomavirus and Cervical Cancer -- Health Economics in the Genomic Age -- Screening for Cancer: Are Resources Being Used Wisely?.
Internal medicine.
Oncology  .
Human genetics.
Gynecology .
Gastroenterology .
Respiratory organs-Diseases.
Internal Medicine.
Oncology.
Human Genetics.
Gynecology.
Gastroenterology.
Pneumology/Respiratory System.